Delivery Order SPE2DR25D1106-SPE2DR26FJB2L
- Not listed
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on October 27, 2025, for the supply of Vasopressin 20 Unit/mL vials, a critical pharmaceutical used in emergency medical situations. This competitively awarded, non-set-aside delivery order has a ceiling value of $2,084.16 and is scheduled for completion by October 28, 2025. The work will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, with firm fixed pricing...
- The Defense Logistics Agency awarded a delivery order valued at $1,696.06 to AmerisourceBergen Drug Corp for Vasopressin 20 Unit/ML Vial on June 18, 2025, with an ultimate completion date of June 20, 2025. This delivery order represents a firm fixed price contract with no set-aside designation, performed at the contractor's Conshohocken, Pennsylvania location. The award is a child contract issued under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract (IDC) with DLA Troop Support...
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp for Vasopressin 20 Unit/ML vials with a ceiling value of $2,124.78. This firm fixed price delivery order, awarded on August 25, 2025, with an ultimate completion date of August 26, 2025, represents a small-value pharmaceutical procurement supporting federal medical supply needs. The contract carries no set-aside designation and was competitively awarded through open competition. AmerisourceBergen Drug...
- This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, was issued by the Defense Logistics Agency (DLA) Troop Support Medical. The $3,242.87 firm fixed-price delivery order is for the supply of 20 unit/mL vials of the drug vasopressin, with a completion date of November 16, 2023. Amerisourcebergen holds a larger $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for providing a...
- This federal contract award was issued by the Defense Logistics Agency (DLA), a defense agency, to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a Delivery Order with a Firm Fixed Price pricing type, valued at $1,224.93, and has an ultimate completion date of July 10, 2025. The contract is not set aside and is for the supply of VASOPRESSIN 20 UNIT/ML VIALML, a pharmaceutical product. Amerisourcebergen Drug Corp holds a...
- This federal contract award was made by the Defense Logistics Agency (DLA) to the Corporate Office division of Amerisourcebergen Drug Corp, a major pharmaceutical distribution company. The $2,060.94 firm fixed-price delivery order is for the supply of 20 unit/mL vials of the drug Vasopressin, with a completion date of April 26, 2024. Amerisourcebergen holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to $999,999,999.00 through December 31, 2025....
- This federal contract award, valued at $11,118.94, was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The contract is for the delivery of 4566082748 units of VASOPRESSIN 1ML 25S, a critical medical commodity. This is a firm fixed-price delivery order contract with an ultimate completion date of October 15, 2024. Amerisourcebergen is the prime contractor, and the contract is not designated as a set-aside....
- The Defense Logistics Agency awarded a $403,000 firm fixed price delivery order to Amerisourcebergen Drug Corporation for 20 unit/mL vials of vasopressin. The order was placed under an indefinite-delivery/indefinite-quantity contract vehicle to supply pharmaceutical products and services to the Department of Defense. Performance will take place at Amerisourcebergen's facility in Conshohocken, Pennsylvania over a one day period in mid-August 2023. No subcontractors or set aside designations...
- This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to the prime contractor Amerisourcebergen Drug Corp. The contract, valued at $3,553.75, is for the delivery of Vasopressin 20 unit/mL vial, a critical medical supply. The award is a Delivery Order under an Indefinite Delivery Contract (IDC) held by Amerisourcebergen, valued at $999,999,999, which serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and...
- The Defense Logistics Agency awarded a delivery order valued at $1,168.50 to AmerisourceBergen Drug Corp for Vasostrict (vasopressin) 20 unit/mL vials on October 31, 2025, with completion scheduled for November 3, 2025. This firm fixed-price contract, which involved no set-aside designation, will be performed at the company's corporate office location in Conshohocken, Pennsylvania. The award represents a small-value order within the scope of AmerisourceBergen's broader federal pharmaceutical...
- SPE2DR25D1106Indefinite Delivery Contract
- SPE2DR25D1106-SPE2DR26FJB2LDelivery Order
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on November 26, 2025, for the supply of Vasopressin 20 Unit/mL vials valued at $2,813.85. This is a firm fixed-price delivery order with no set-aside designation, issued under a competitive procurement process. The product will be delivered to AmerisourceBergen's facility in Conshohocken, Pennsylvania, with an ultimate completion date of November 28, 2025. This delivery order represents a routine pharmaceutical supply transaction executed under the company's broader relationship with the federal government's medical supply chain. This award is a child contract issued under AmerisourceBergen Drug Corp's substantial Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00 and extending through December 2026. As a major pharmaceutical distributor and healthcare solutions provider, AmerisourceBergen serves as a critical vendor for federal military and veteran healthcare systems, supplying an extensive portfolio of medications, vaccines, medical devices, and specialized healthcare commodities across multiple therapeutic domains. The parent IDC functions as a comprehensive global pharmaceutical support vehicle enabling AmerisourceBergen to fulfill medical supply needs for the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems worldwide.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $2.8k | 11/25/25 |